Phil Greenberg (IMAGE)

Fred Hutchinson Cancer Center

Phil Greenberg

Caption

'Our results highlight that driver mutations, which theoretically would be the most effective antigens to target because they represent the basis for a tumor behaving as a tumor, are not immunologically silent and can indeed be recognized,' said Fred Hutchinson Cancer Research Center immunologist Dr. Phil Greenberg, who led the study.

Credit

Fred Hutch News Service

Usage Restrictions

No restrictions, but please attribute appropriately.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.